Clearside Biomedical, Inc. Liquidation Value
CLSDQ
Other
Cash & Equivalents
$6.80M
As of 2025-09-30
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $6.80M
Total Obligations: -$3.22M
$3.58M
Per share: $0.68
Period: 2025-09-30
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $6.80M
AR: $266,000
Total Obligations: -$3.22M
$3.85M
Per share: $0.74
Period: 2025-09-30
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $6.80M
AR: $266,000
Inventory: $0
Total Obligations: -$3.22M
$3.85M
Per share: $0.74
Period: 2025-09-30
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $3.58M | $0.68 |
| Liquid Liquidation Value | $3.85M | $0.74 |
| Operating Liquidation Value | $3.85M | $0.74 |
Key Components (as of 2025-09-30)
| Cash & Equivalents | $6.80M |
| Accounts Receivable | $266,000 |
| Inventory | N/A |
| Current Liabilities | $2.77M |
| Long-term Debt | N/A |
| Op. Lease Liability | $446,000 |
| Finance Lease | N/A |
| Shares Outstanding | 5.2M |
Explore all 80 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $6.80M | $266,000 | N/A | $796,000 | $2.77M | N/A | $446,000 | N/A |
| 2025-06-30 | $9.38M | $816,000 | N/A | $1.13M | $3.05M | N/A | $533,000 | N/A |
| 2025-03-31 | $13.63M | $1.54M | N/A | $1.91M | $5.01M | N/A | $619,000 | N/A |
| 2024-12-31 | $20.02M | $507,000 | N/A | $1.45M | $4.79M | N/A | $703,000 | N/A |
| 2024-09-30 | $13.89M | $788,000 | N/A | $2.36M | $5.59M | N/A | $785,000 | N/A |
| 2024-06-30 | $18.24M | $0 | N/A | $1.58M | $5.87M | N/A | $863,000 | N/A |
| 2024-03-31 | $35.35M | $0 | N/A | $1.36M | $5.95M | N/A | $939,000 | N/A |
| 2023-12-31 | $28.92M | $467,000 | N/A | $2.21M | $6.81M | N/A | $1.01M | N/A |
▼ Community Notes